Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionEvercore Wealth Management, LLC
Latest Disclosed Ownership2,098 shares
Latest Disclosed Value $ 936,841
Evercore Wealth Management, LLC reports 0.38% decrease in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 15, 2026 - Evercore Wealth Management, LLC filed a 13F-HR form disclosing ownership of 2,098 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $936,841 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,106 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -0.38% during the quarter. The current value of the position is $898,657 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,098 -8 -0.38 937 -1.89 0.0079
2026-02-17 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,106 0 0.00 955 15.78 0.0140
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,106 -22 -1.03 825 -12.99 0.0121
2025-08-14 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,128 27 1.29 947 -6.97 0.0147
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,101 278 15.25 1,019 38.69 0.0164
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,823 -50 -2.67 734 -15.73 0.0110
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,873 0 0.00 871 -0.68 0.0131
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,873 0 0.00 878 12.15 0.0138
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,873 12 0.64 783 3.30 0.0123
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,861 139 8.07 757 26.59 0.0127
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,722 2 0.12 599 -1.16 0.0112
2023-08-04 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,720 19 1.12 605 13.08 0.0111
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,701 22 1.31 536 10.54 0.0107
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,679 35 2.13 485 1.68 0.0102
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,644 50 3.14 476 6.01 0.0107
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,594 0 0.00 449 7.93 0.0095
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,594 -28 -1.73 416 16.85 0.0074
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,622 -31 -1.88 356 18.67 0.0058
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,653 4 0.24 300 -9.64 0.0054
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,649 -276 -14.34 332 -19.81 0.0061
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,925 -451 -18.98 414 -26.33 0.0082
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,376 -25 -1.04 562 -13.94 0.0121
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,401 62 2.65 653 -3.83 0.0160
2020-08-13 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,339 -68 -2.83 679 18.50 0.0181
2020-05-14 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,407 440 22.37 573 32.95 0.0189
2020-02-13 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,967 55 2.88 431 33.02 0.0116
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,912 10 0.53 324 -7.16 0.0095
2019-08-13 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,902 31 1.66 349 1.45 0.0106
2019-05-14 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,871 42 2.30 344 13.53 0.0111
2019-02-13 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,829 -23 -1.24 303 -15.13 0.0114
2018-11-13 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,852 -278 -13.05 357 -1.38 0.0114
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,130 -200 -8.58 362 -4.74 0.0124
2018-05-14 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,330 -400 -14.65 380 -7.09 0.0145
2018-02-13 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,730 -325 -10.64 409 -11.85 0.0152
2017-11-13 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,055 0 0.00 464 17.77 0.0181
2017-08-11 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,055 0 0.00 394 17.96 0.0152
2017-05-12 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,055 -20 -0.65 334 47.79 0.0131
2017-02-08 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,075 2,755 860.94 226 707.14 0.0094
2016-11-10 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 320 0 0.00 28 0.00 0.0012
2016-09-20 2016-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 320 65 25.49 28 40.00 0.0012
2016-08-01 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 320 28
2016-05-02 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 255 -29 -10.21 20 -44.44 0.0009
2016-02-16 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 284 29 11.37 36 38.46 0.0017
2015-11-16 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 255 0 0.00 26 -18.75 0.0012
2015-08-06 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 255 -8 -3.04 32 0.00 0.0014
2015-05-06 2015-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 263 -18 -6.41 32 -5.88 0.0015
2015-02-13 2014-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 281 26 10.20 34 25.93 0.0017
2014-11-13 2014-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 255 0 0.00 27 8.00 0.0014
2014-08-14 2014-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 255 -200 -43.96 25 -24.24 0.0013
2014-05-15 2014-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 455 0 0.00 33 -2.94 0.0019
2014-02-11 2013-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 455 -100 -18.02 34 -19.05 0.0019
2013-11-13 2013-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 555 100 21.98 42 16.67 0.0024
2013-08-14 2013-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 455 455 36 0.0020
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.